A study to Investigate the Effect of Intraperitoneal Levobupivacaine on Post Operative Laparoscopic Pain - LAPLIQUID study
Phase 1
- Conditions
- Post operative pain
- Registration Number
- EUCTR2009-011207-23-GB
- Lead Sponsor
- Hull and east Yorkshire Hospital NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 109
Inclusion Criteria
Inclusion criteria will be all women about to undergo minor laparoscopic surgery.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusions will be women with a BMI>35 or with an ASA >2, known previous adverse reaction or any contraindication to levobupivacaine. It is also necessary to exclude women who have a painful condition immediately prior to the surgery.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: The principle research question is whether leaving a local anaesthetic solution in the abdomen after keyhole surgery improves pain relief.;Secondary Objective: Secondary research questions are whether leaving a local anaesthetic solution in the abdomen after keyhole surgery reduces the need for other pain killing agents and reduces the duration of hospital stay.;Primary end point(s): The pain score in the evening after surgery.(8hours)
- Secondary Outcome Measures
Name Time Method